Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Politics Report.
Press releases published on August 6, 2025
NEURONES: Organic growth up 5.3% in 2nd quarter 2025
GlobeNewswire
·
August 6, 2025
PRESS INFORMATION Nanterre, August 6, 2025 (after trading) Heading: 1st half 2025 revenues Organic growth up 5.3% in 2nd quarter 2025 Revenues (millions of euros) 2024 2025 Growth of which organic Q1 204.9 214.1 + 4.5% + 3.9% Q2 197.5 210.2 + 6.4% + …
NEURONES : + 5,3% de croissance organique au 2e trimestre 2025
GlobeNewswire
·
August 6, 2025
INFORMATION PRESSE Nanterre, le 6 août 2025 (après Bourse) Rubrique : C.A. 1er semestre 2025 + 5,3% de croissance organique au 2e trimestre 2025 C.A. (en millions d’euros) 2024 2025 Croissance dont organique 1er trimestre 204,9 214,1 + 4,5% + 3,9% …
Jelenew Supports the Growth of Women's Cycling at 2025 La Périgord Ladies
GlobeNewswire
·
August 6, 2025
Jelenew Supports the Growth of Women’s Cycling at 2025 La Périgord Ladies New Start. Jelenew Empowers Elite Cyclists Through Performance. Jelenew proudly participated in the 2025 La Périgord Ladies race in France, reinforcing its commitment to advancing …
Vocodia Holdings Corp. Announces Regulation A Offering to Raise Up to $3 Million
GlobeNewswire
·
August 6, 2025
BOCA RATON, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Vocodia Holdings Corp. (OTC: VHAI), a conversational AI technology company, today announced that is Regulation A offering to raise up to $3 million has been qualified by the Securities and Exchange …
CoinShares XBT Provider AB (Publ) Publishes Half Year Interim Report 2025
GlobeNewswire
·
August 6, 2025
06 August 2025 CoinShares XBT Provider AB (Publ) LEI: 549300HGWKR2Q5T8GK64 CoinShares XBT Provider AB (Publ) Publishes Half Year Interim Report 2025 Stockholm, 06 August 2025 - CoinShares XBT Provider AB (Publ) (the "Company") is pleased to announce that …
Galapagos NV kondigt aan dat GLPG5101 de status van Regenerative Medicine Advanced Therapy (RMAT) van de FDA krijgt voor de behandeling van recidief/refractair mantelcellymfoom
GlobeNewswire
·
August 6, 2025
Mechelen, België; 6 augustus 2025, 7.30 uur CET; gereglementeerde informatie – voorwetenschap – Galapagos NV (Euronext …
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
GlobeNewswire
·
August 6, 2025
Mechelen, Belgium; August 6, 2025, 7:30 CET; regulated information – inside information – Galapagos NV (Euronext …
Communiqué de presse : Sanofi finalise l’acquisition de Vigil Neuroscience, Inc.
GlobeNewswire
·
August 6, 2025
Sanofi finalise l’acquisition de Vigil Neuroscience, Inc. Paris, le 6 août 2025. Sanofi annonce la finalisation de l’acquisition de Vigil Neuroscience, Inc. (« Vigil »). Cette acquisition renforce le pipeline de Sanofi en neurologie avec le VG-3927, un …
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
GlobeNewswire
·
August 6, 2025
Sanofi completes the acquisition of Vigil Neuroscience, Inc. Paris, August 6, 2025. Sanofi announces the completion of its acquisition of Vigil Neuroscience, Inc. (“Vigil”). This acquisition strengthens Sanofi’s early-stage pipeline in neurology with VG- …
Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in July 2025 of 3.1% Compared to 2024
GlobeNewswire
·
August 6, 2025
GUADALAJARA, Mexico, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger traffic figures for July 2025, compared with July 2024. During …